Pharmaceutical

Mind-altering ketamine becomes latest pain treatment, despite little research or regulation

Mind-altering ketamine becomes latest pain treatment, d...

Nov 7, 2023

With limited research on ketamine's effectiveness against pain, some experts wor...

Senate confirms Monica Bertagnolli as NIH director

Senate confirms Monica Bertagnolli as NIH director

Nov 7, 2023

Longtime cancer doctor Monica Bertagnolli is finally heading to the NIH director...

Congenital syphilis cases in the U.S. have skyrocketed, CDC says

Congenital syphilis cases in the U.S. have skyrocketed,...

Nov 7, 2023

The number of babies born with congenital syphilis in the U.S. has soared over t...

STAT+: FTC challenges several big drugmakers over inaccurate or improper patent listings

STAT+: FTC challenges several big drugmakers over inacc...

Nov 7, 2023

The FTC is challenging more than 100 patents on brand-name medicines that were i...

TLM-005 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-005 is under clinical development by Therillume and currently in Phase I for...

TLM-004 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-004 is under clinical development by Therillume and currently in Phase I for...

TLM-003 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-003 is under clinical development by Therillume and currently in Phase I for...

StromaForte by Swedish StromaBio for Cardiovascular Dis...

Nov 6, 2023

StromaForte is under clinical development by Swedish StromaBio and currently in ...

Fulvestrant by Kashiv BioSciences for Metastatic Breast...

Nov 6, 2023

Fulvestrant is under clinical development by Kashiv BioSciences and currently in...

TLM-101 by Therillume for Neurofibromatoses Type I (Von...

Nov 6, 2023

TLM-101 is under clinical development by Therillume and currently in Phase I for...

TLM-006 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023

TLM-006 is under clinical development by Therillume and currently in Phase I for...

AWT-020 by Anwita Biosciences for Lymphoma: Likelihood ...

Nov 6, 2023

AWT-020 is under clinical development by Anwita Biosciences and currently in Pha...

StromaForte by Swedish StromaBio for Ageing: Likelihood...

Nov 6, 2023

StromaForte is under clinical development by Swedish StromaBio and currently in ...

StromaForte by Swedish StromaBio for Osteoarthritis: Li...

Nov 6, 2023

StromaForte is under clinical development by Swedish StromaBio and currently in ...

STAT turns 8: A letter from the executive editor

STAT turns 8: A letter from the executive editor

Nov 5, 2023

Today STAT turns 8! Read a letter from our executive editor @rickberke on the mi...

STAT+: Senate bill would permanently extend Covid-era rules on telehealth addiction treatment

STAT+: Senate bill would permanently extend Covid-era r...

Nov 5, 2023

A bipartisan bill would permanently extend a Covid-era policy that allowed patie...